Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
114M
-
Number of holders
-
37
-
Total shares
-
14.1M
-
Shares change
-
-1.75M
-
Total reported value, excl. options
-
$23.9M
-
Value change
-
-$3.1M
-
Number of buys
-
10
-
Number of sells
-
-22
-
Price
-
$1.70
Significant Holders of FATE THERAPEUTICS INC - Common Stock (FATE) as of Q2 2016
37 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock as of Q2 2016.
FATE THERAPEUTICS INC - Common Stock (FATE) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 114M outstanding shares and own 12.37% of the company stock.
Largest 10 shareholders include FMR LLC (4.31M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.26M shares), Redmile Group, LLC (1.5M shares), VANGUARD GROUP INC (658K shares), FRANKLIN RESOURCES INC (500K shares), Belmont Global Advisors, Inc. (400K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (395K shares), Board of Trustees of The Leland Stanford Junior University (291K shares), and Lombard Odier Asset Management (USA) Corp (256K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.